Growth Score
pts
Heat Score
pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4730613
Medical AI / Software as a Medical Device (SaMD)
About the Company
RADAX.AI is a Taipei-based medical AI company developing AI-powered neuroimaging Software as a Medical Device (SaMD) for MRI/MRA. Our flagship product, RDX-Aneurysm, helps radiologists detect subtle, small, or multiple intracranial aneurysms on routine MRA before rupture. By turning routine imaging into earlier preventive insights, RADAX.AI
aims to improve diagnostic quality, reduce preventable misses, and make every scan clinically meaningful. The company combines neuroimaging AI, clinical validation, hospital workflow integration, and SaMD commercialization expertise, with FDA Q-sub completed and TFDA Class II pathway ongoing.
